Application in Oncology to Account for 50% of Overall Consumption of Radiopharmaceuticals
The penetration of radio-therapeutics is expected to be the biggest move in the global radiopharmaceuticals market. Radiopharmaceuticals are increasingly used in the diagnosis and treatment of several diseases such as cancer, cardiovascular diseases, and neurological disorders owing to their characteristics of radioactive decay and the ability of targeted therapeutic irradiation. The global market for radiopharmaceuticals is set to witness a healthy CAGR of 5% during the forecast period of 2019 – 2029. Increasing the application of nuclear medicine in oncology will… Keep Reading
